IDEMIA Will Present Its 2018 Annual Financial Results to Investors on February 20, 2019
IDEMIA, the world leader in Augmented Identity, today announced that it will present its 2018 annual financial results to investors on Wednesday February 20, 2019.
Yann Delabrière (CEO), Laurent Lemaire (CFO), and Frédéric Beylier (COO) will be presenting the financial results and taking questions the same day at 4:00 pm CET (3:00 pm London Time / 10:00 am New York Time).
For more information, please refer to our website: http://investors.oberthur.com
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect, travel and vote), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With close to $3 billion in revenues and 13,000 employees around the world, IDEMIA serves clients in 180 countries.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
PA-TELEFLEX21.3.2019 12:32:08 CET | Pressemeddelelse
Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate
CA-SMITHS-DETECTION21.3.2019 12:25:08 CET | Pressemeddelelse
Smiths Detection Now Has Two Scanners with ECAC Standard 3.1 Approval
APR21.3.2019 11:32:12 CET | Pressemeddelelse
Rare Diseases: PKU GOLIKE® Debuts in Germany
HOLOGIC21.3.2019 11:02:09 CET | Pressemeddelelse
Hologic Opens State-Of-The-Art Learning and Experience Centre In Zaventem, Belgium
SAMSUNG-BIOEPIS-CO-LTD21.3.2019 10:04:05 CET | Pressemeddelelse
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer
CA-TRADESHIFT21.3.2019 09:02:07 CET | Pressemeddelelse
Tradeshift partnership with FRDM wins Treasury4Good Award for Best CSR/ESG Technology Solution
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum